首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >Validity of international association for the study of lung cancer proposals for the revision of N descriptors in lung cancer
【24h】

Validity of international association for the study of lung cancer proposals for the revision of N descriptors in lung cancer

机译:国际肺癌研究协会对肺癌N描述符的修订的有效性

获取原文
获取原文并翻译 | 示例

摘要

Objective: This study was conducted to assess the validity of the pending suggestions for N descriptors by the International Association for the Study of Lung Cancer. Methods: Medical records from 1032 patients with non-small cell lung cancer who had pulmonary resection and proven stage I-III were retrospectively reviewed. Lymph node stations were grouped together into six "zones": peripheral or hilar for N1 and upper or lower mediastinal, aortopulmonary, and subcarinal for N2. Survival was analyzed according to the proposed subdividing N descriptors: single-zone N1 (N1a), multizone N1 (N1b), single-zone N2 (N2a), and multizone N2 (N2b). Results: The 5-year survival rate was 63.8% for N0, 42.3% for N1a, 36.5% for N1b, 35.8% for N2a, and 17.4% for N2b. There were three distinct prognostic groups for N1 and N2 nodes: N1a, N1b or N2a, and N2b disease. In multivariate analysis, age, sex, type of surgery, T stage, and node status were independent prognostic factors. Hazard ratios versus N0 for N1a, N1b or N2b, N2b, and N3 were 1.577, 2.164, 3.291, and 5.897, respectively. Conclusion: Amalgamating lymph node stations into zones and subdividing N descriptors described a significant stepwise deterioration of disease status. Although more studies are needed, the lymph node zone and subdivided N descriptors could be one of step for desirable approach of forthcoming tumor, node, metastasis classification in non-small cell lung cancer.
机译:目的:本研究旨在评估国际肺癌研究协会针对N描述符的待定建议的有效性。方法:回顾性分析1032例非小细胞肺癌行肺切除术并证实I-III期的患者的病历。淋巴结站被分为六个“区域”:N1的周围或肺门,N2的上或下纵隔,主肺和下inal骨。根据提议的细分N个描述符对生存期进行了分析:单区域N1(N1a),多区域N1(N1b),单区域N2(N2a)和多区域N2(N2b)。结果:N0的5年生存率分别为63.8%,N1a 42.3%,N1b 36.5%,N2a 35.8%和N2b 17.4%。 N1和N2淋巴结分为三个不同的预后组:N1a,N1b或N2a和N2b疾病。在多因素分析中,年龄,性别,手术类型,T分期和淋巴结状况是独立的预后因素。 N1a,N1b或N2b,N2b和N3的危害比与N0分别为1.577、2.164、3.291和5.897。结论:将淋巴结站合并成区域并细分N个描述子描述了疾病状态的显着逐步恶化。尽管还需要进行更多的研究,但淋巴结区和细分的N描述子可能是非小细胞肺癌即将出现的肿瘤,淋巴结,转移分类的理想方法之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号